ATXI - Avenue Therapeutics Inc Stock Price, Fair Value and News

2.72USD-0.15 (-5.23%)Market Closed

Market Summary

USD2.72-0.15

Market Closed

-5.23%

ATXI Stock Price

View Fullscreen

ATXI RSI Chart

ATXI Valuation

Market Cap

2.7M

Price/Earnings (Trailing)

-0.37

Price/Free Cashflow

-0.25

ATXI Price/Sales (Trailing)

ATXI Profitability

Return on Equity

-255.11%

Return on Assets

-218.58%

Free Cashflow Yield

-407.24%

ATXI Fundamentals

ATXI Earnings

Earnings (TTM)

-7.2M

Earnings Growth (Yr)

42.79%

Earnings Growth (Qtr)

-804.86%

Breaking Down ATXI Revenue

Last 7 days

-13.2%

Last 30 days

-17.0%

Last 90 days

-52.1%

Trailing 12 Months

-96.3%

How does ATXI drawdown profile look like?

ATXI Financial Health

ATXI Investor Care

Shares Dilution (1Y)

791.03%

About Avenue Therapeutics Inc

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.

CEO	Dr. Alexandra MacLean M.D.
WEBSITE	avenuetx.com
INDUSTRY	Biotechnology
EMPLOYEES	2

Avenue Therapeutics Inc Frequently Asked Questions

What is the ticker symbol for Avenue Therapeutics Inc? What does ATXI stand for in stocks?

ATXI is the stock ticker symbol of Avenue Therapeutics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Avenue Therapeutics Inc (ATXI)?

As of Thu Jul 25 2024, market cap of Avenue Therapeutics Inc is 2.7 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ATXI stock?

You can check ATXI's fair value in chart for subscribers.

Is Avenue Therapeutics Inc a good stock to buy?

The fair value guage provides a quick view whether ATXI is over valued or under valued. Whether Avenue Therapeutics Inc is cheap or expensive depends on the assumptions which impact Avenue Therapeutics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ATXI.